In Brief: Chemrite Industries
This article was originally published in The Rose Sheet
Executive Summary
Chemrite Industries: Receives Feb. 7 FDA warning letter charging the Lannon, WI-based firm with failure to meet written manufacturing specifications for its antibacterial soap. The letter notes that the soap is adulterated since the methods used in its manufacturing, processing, packaging or holding do not conform to GMP requirements. The agency is also charging Chemrite with failure to document and maintain complete batch history records. Chemrite is required to respond within 15 working days after receiving the letter...